loading
Adverum Biotechnologies Inc stock is traded at $2.32, with a volume of 79,688. It is down -2.93% in the last 24 hours and up +1.75% over the past month. Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
See More
Previous Close:
$2.39
Open:
$2.35
24h Volume:
79,688
Relative Volume:
0.25
Market Cap:
$48.47M
Revenue:
-
Net Income/Loss:
$-94.11M
P/E Ratio:
-0.386
EPS:
-6.01
Net Cash Flow:
$-86.06M
1W Performance:
-14.07%
1M Performance:
+1.75%
6M Performance:
-45.02%
1Y Performance:
-69.35%
1-Day Range:
Value
$2.27
$2.4304
1-Week Range:
Value
$2.27
$2.8169
52-Week Range:
Value
$1.78
$8.56

Adverum Biotechnologies Inc Stock (ADVM) Company Profile

Name
Name
Adverum Biotechnologies Inc
Name
Phone
(650) 649-1004
Name
Address
100 CARDINAL WAY, REDWOOD CITY, CA
Name
Employee
155
Name
Twitter
@adverumbio
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
ADVM's Discussions on Twitter

Compare ADVM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ADVM
Adverum Biotechnologies Inc
2.32 49.93M 0 -94.11M -86.06M -6.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-25-24 Initiated Oppenheimer Outperform
Apr-30-24 Initiated H.C. Wainwright Buy
Jul-07-22 Upgrade Truist Hold → Buy
Jul-23-21 Downgrade Cantor Fitzgerald Overweight → Neutral
May-03-21 Downgrade SVB Leerink Outperform → Mkt Perform
Apr-29-21 Downgrade Chardan Capital Markets Buy → Neutral
Apr-29-21 Downgrade RBC Capital Mkts Outperform → Sector Perform
Apr-29-21 Downgrade Truist Buy → Hold
Dec-16-20 Initiated UBS Neutral
Nov-12-20 Upgrade Raymond James Underperform → Mkt Perform
Jun-26-20 Downgrade Raymond James Mkt Perform → Underperform
May-13-20 Initiated RBC Capital Mkts Outperform
May-05-20 Upgrade SunTrust Hold → Buy
Apr-28-20 Initiated Goldman Buy
Mar-16-20 Initiated SVB Leerink Outperform
Feb-10-20 Upgrade Cantor Fitzgerald Neutral → Overweight
Feb-10-20 Upgrade Chardan Capital Markets Neutral → Buy
Oct-15-19 Reiterated Chardan Capital Markets Neutral
Sep-13-19 Reiterated Chardan Capital Markets Neutral
Jun-14-19 Resumed Raymond James Mkt Perform
Nov-02-18 Downgrade Raymond James Outperform → Mkt Perform
Nov-02-18 Downgrade SunTrust Buy → Hold
Sep-21-18 Initiated Cantor Fitzgerald Overweight
Aug-30-18 Initiated SunTrust Buy
Feb-15-18 Resumed Piper Jaffray Overweight
Oct-12-17 Initiated Raymond James Outperform
View All

Adverum Biotechnologies Inc Stock (ADVM) Latest News

pulisher
01:41 AM

Adverum Biotechnologies Inc. stock prediction for this weekAlgorithmic Prediction of Market Breakouts - Newser

01:41 AM
pulisher
01:20 AM

What to do if you’re stuck in Adverum Biotechnologies Inc.Entry Signal Generator with Risk Metrics - Newser

01:20 AM
pulisher
Aug 01, 2025

Is this a good reentry point in Adverum Biotechnologies Inc.Weekly Movement Forecast With Chart Signals - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

Pattern recognition hints at Adverum Biotechnologies Inc. upsideFree Sector Based Breakout Stock Forecast - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

How high can Adverum Biotechnologies Inc. stock price go in 2025Intraday Price Action Forecast Planner - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

When is Adverum Biotechnologies Inc. stock expected to show significant growthWealth Building Target Finder For Every Investor - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Is it the right time to buy Adverum Biotechnologies Inc. stockPre Market Planner For Beginners - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 30, 2025

What makes Adverum Biotechnologies Inc. stock price move sharplyFree Profit Target Stock Opportunity Monitor - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Published on: 2025-07-31 02:50:15 - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Leading vs lagging indicators on Adverum Biotechnologies Inc. performanceDeep Stock Performance and Volatility Analysis - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

Adverum Biotechnologies Inc. Could See a Relief Rally From SupportOversold Bounce Stock Play Ideas Gain Attention - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Adverum Biotechnologies Inc. Stock Lags Behind Sector BenchmarksEarly Entry Tips With Low Risk Zone Shared - beatles.ru

Jul 29, 2025
pulisher
Jul 28, 2025

What are Adverum Biotechnologies Inc. company’s key revenue driversBest Dividend Entry Points For Every Investor - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Adverum Biotechnologies Inc. stock overvalued or undervaluedMassive portfolio appreciation - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Does Adverum Biotechnologies Inc. stock perform well during market downturnsUnmatched market performance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Adverum Biotechnologies Inc. stockAchieve rapid portfolio growth with expert help - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Adverum Biotechnologies Inc. generate profit in a changing economyInvest confidently with actionable market data - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Adverum Biotechnologies Inc. a growth stock or a value stockExplosive trading opportunities - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Should I hold or sell Adverum Biotechnologies Inc. stock in 2025High-profit trading signals - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Adverum Biotechnologies Inc. in the next 12 monthsCapitalize on market momentum for profits - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What is Adverum Biotechnologies Inc. company’s growth strategySuperior capital gains - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the technical indicators suggesting about Adverum Biotechnologies Inc.Maximize returns with data-driven strategies - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How many analysts rate Adverum Biotechnologies Inc. as a “Buy”Over 200% growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

why adverum biotechnologies inc. stock attracts strong analyst attentionTop Gaining Low Risk Assets - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Is Adverum Biotechnologies Inc. stock a growth or value playBreakout portfolio performance - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Adverum Biotechnologies Inc. Stock Analysis and ForecastUnrivaled growth potential - Autocar Professional

Jul 25, 2025
pulisher
Jul 23, 2025

What analysts say about Adverum Biotechnologies Inc. stockTurbocharged investment results - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Adverum Biotechnologies Inc. a good long term investmentHigh-octane financial growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Adverum Biotechnologies Inc. stock priceBreakneck growth rates - jammulinksnews.com

Jul 22, 2025

Adverum Biotechnologies Inc Stock (ADVM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Adverum Biotechnologies Inc Stock (ADVM) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Seyedkazemi Setareh
CHIEF DEVELOPMENT OFFICER
May 15 '25
Sale
2.00
924
1,848
13,768
Fischer Laurent
CEO, PRESIDENT AND DIRECTOR
May 15 '25
Sale
2.00
9,126
18,252
87,488
Leonard Braden Michael
10% Owner
Mar 26 '25
Buy
5.04
20,407
102,841
125,207
Leonard Braden Michael
10% Owner
Mar 27 '25
Buy
5.19
16,593
86,089
141,800
Leonard Braden Michael
10% Owner
Apr 22 '25
Buy
3.00
300,000
900,000
3,057,526
Leonard Braden Michael
10% Owner
Apr 23 '25
Buy
2.98
50,000
148,950
191,800
Leonard Braden Michael
10% Owner
Mar 31 '25
Buy
4.38
19,566
85,668
2,742,317
Leonard Braden Michael
10% Owner
Apr 02 '25
Buy
4.04
15,209
61,408
2,757,526
Leonard Braden Michael
10% Owner
Mar 26 '25
Buy
5.04
20,407
102,841
125,207
Leonard Braden Michael
10% Owner
Mar 18 '25
Buy
4.69
62,341
292,418
2,667,161
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):